A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Immuneering Corporation
Immuneering Corporation
Karyopharm Therapeutics Inc
Santa Maria Biotherapeutics
Novartis
Celldex Therapeutics
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center